BioSenic SA
Develops therapies for autoimmune diseases, inflammation, and bone disorders.
BIOS | BR
Overview
Corporate Details
- ISIN(s):
- BE0970179827 (+1 more)
- LEI:
- 549300HFIIMTOP1DFR76
- Country:
- Belgium
- Address:
- RUE GRANBONPRÉ 11, 1435 MONT-ST-GUIBERT
- Website:
- http://www.biosenic.com/
Description
BioSenic SA is a biotechnology company focused on developing innovative treatments for autoimmune diseases, inflammatory conditions, and bone disorders. The company's core activities are centered on two main technology platforms: one based on arsenic trioxide (ATO) for its immunomodulatory properties, and another involving allogeneic cell therapy for tissue repair and regeneration. BioSenic's objective is to address significant unmet medical needs in the fields of regenerative and immune medicine by advancing its clinical assets through development.
Unlock This Filing & Millions More
You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.
Filings
| Date | Filing | Language | Type / Size | Actions | |
|---|---|---|---|---|---|
| 2023-09-27 07:00 |
BIOS_PR_FR_ Post-hoc Results_Clinical Trial 3_cGvHD_Final.pdf
|
French | PDF • 235.2 KB | ||
| 2023-09-19 00:00 |
BIOS_PR SScArticle_EN_230918_Final.pdf
|
English | PDF • 241.4 KB | ||
| 2023-09-19 00:00 |
BIOS_PR SScArticle_FR_230919_Final.pdf
|
French | PDF • 235.3 KB | ||
| 2023-09-14 00:00 |
BIOS_PR creditors_EN_2023 09 14_Final.pdf
|
English | PDF • 222.0 KB | ||
| 2023-09-14 00:00 |
BIOS_PR_creditors_FR_2023 09 14_Final.pdf
|
French | PDF • 200.2 KB | ||
| 2023-09-07 00:00 |
BIOS_Report_H1Y23_EN_Final.pdf
|
English | PDF • 539.3 KB | ||
| 2023-09-07 00:00 |
BIOS_Rapport_H1Y23_FR_Final.pdf
|
French | PDF • 461.6 KB | ||
| 2023-09-01 07:00 |
BIOS_PR_2023-September_Denominator_EN_Final.pdf
|
English | PDF • 220.6 KB | ||
| 2023-09-01 07:00 |
BIOS_PR_2023-septembre_Denominator_FR_Final.pdf
|
French | PDF • 254.6 KB | ||
| 2023-08-24 00:00 |
BIOS_PR_2023 08 25_Patent SEAL_ATO-Cu_EN_Final.pdf
|
English | PDF • 242.3 KB | ||
| 2023-08-24 00:00 |
BIOS_PR_2023 08 25_Patent SEAL_ATO-Cu_FR_Final.pdf
|
French | PDF • 285.0 KB | ||
| 2023-08-03 00:00 |
BIOS_PR_2023-Aout_Denominator_FR_Final.pdf
|
French | PDF • 253.3 KB | ||
| 2023-08-03 00:00 |
BIOS_PR_2023-August_Denominator_EN_Final.pdf
|
English | PDF • 221.1 KB | ||
| 2023-07-10 07:00 |
BIOS_PR standstill_EN_2023 07 10_Final.pdf
|
English | PDF • 213.7 KB | ||
| 2023-07-10 07:00 |
BIOS_PR standstill_FR_2023 07 10_Final.pdf
|
French | PDF • 242.4 KB |
Automate Your Workflow. Get a real-time feed of all BioSenic SA filings delivered via API.
Market Data
Market Data Not Available
Financials & KPIs
Unlock Full Financials for BioSenic SA
This data is available as part of our premium data solutions. Contact our team for access.
Need More History? Access decades of standardized financials for BioSenic SA via our API.
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| 2024-08-16 | Rieger Francois | Board | Sell | 2,500,000 | 25,000.00 EUR |
| 2024-08-06 | Rieger Francois | Board | Sell | 868,653 | 7,186.87 EUR |
| 2024-08-05 | POMI SCHNEITER VERONIQUE | Board | Sell | 534,750 | 4,331.47 EUR |
| 2024-08-02 | POMI SCHNEITER VERONIQUE | Board | Sell | 193,900 | 1,609.37 EUR |
| 2024-08-01 | Rieger Francois | Board | Sell | 1,236,684 | 11,463.87 EUR |
| 2024-08-01 | POMI SCHNEITER VERONIQUE | Board | Sell | 140,003 | 1,246.03 EUR |
| 2024-07-31 | POMI SCHNEITER VERONIQUE | Board | Sell | 503,771 | 4,685.07 EUR |
| 2024-07-30 | POMI SCHNEITER VERONIQUE | Board | Sell | 360,021 | 3,348.20 EUR |
| 2024-07-29 | POMI SCHNEITER VERONIQUE | Board | Sell | 372,893 | 3,430.62 EUR |
| 2024-07-24 | POMI SCHNEITER VERONIQUE | Board | Sell | 2,168,361 | 21,033.10 EUR |
Peer Companies
